ID   ANAD 63
AC   CVCL_VP94
SY   ANAD-63; ANAD63
DR   Wikidata; Q93325102
RX   CelloPub=CLPUB00440;
RX   PubMed=10837406;
RX   PubMed=21863025;
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu59_Ile66del; Zygosity=Unspecified (CelloPub=CLPUB00440).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
RX   CelloPub=CLPUB00440;
RA   Pirozzi G., Curci A., Errico S., Luongo V., Di Gennaro E.,
RA   Caraco C., Mozzillo N., Lombardi M.L.;
RT   "A new mutation of the B2-microglobuline gene in the ANAD-63, a
RT   melanoma cell line HLA class I negative.";
RL   Eur. J. Immunogenet. 28:327.260-327.260(2001).
//
RX   PubMed=10837406; DOI=10.1093/intimm/12.6.787;
RA   Pirozzi G., Lombari V., Zanzi D., Ionna F., Lombardi M.L., Errico S.,
RA   Ruggiero G., Manzo C.;
RT   "CD40 expressed on human melanoma cells mediates T cell co-stimulation
RT   and tumor cell growth.";
RL   Int. Immunol. 12:787-795(2000).
//
RX   PubMed=21863025; DOI=10.1038/bjc.2011.324; PMCID=PMC3185940;
RA   De Luca A., Lamura L., Strizzi L., Roma C., D'Antonio A.,
RA   Margaryan N.V., Pirozzi G., Hsu M.-Y., Botti G., Mari E., Hendrix M.J.C.,
RA   Salomon D.S., Normanno N.;
RT   "Expression and functional role of CRIPTO-1 in cutaneous melanoma.";
RL   Br. J. Cancer 105:1030-1038(2011).
//